This content is from: Premium
It’s Been a Bad Year for IPOs — But Hedge Funds Are Betting on These New Offerings
Three hedge funds were major investors in a biopharma company that recently went public.
The IPO market as a whole is about to close out its worst year since 2009. Just 71 new issues have been priced so far this year, a figure that’s down 82 percent from the previous year’s 397, which was the most since the
To continue reading, subscribe now to Premium Journalism. Already a subscriber? Login.